Blueprint Medicines Corporation【BPMC】 純利益の推移
機能の使い方
|
（単位：千ドル）
|
純利益
|
前年比（％）
|
|
1Q25
|
496
|
-99.4%
|
|
4Q24
|
-49,956
|
-55.0%
|
|
3Q24
|
-56,274
|
-57.9%
|
|
2Q24
|
-49,994
|
-62.4%
|
|
1Q24
|
89,136
|
-168.8%
|
|
4Q23
|
-110,916
|
-30.1%
|
|
3Q23
|
-133,713
|
+0.4%
|
|
2Q23
|
-132,793
|
-16.9%
|
|
1Q23
|
-129,560
|
+22.2%
|
|
4Q22
|
-158,646
|
-50.2%
|
|
3Q22
|
-133,162
|
+13.6%
|
|
2Q22
|
-159,709
|
+47.3%
|
|
1Q22
|
-105,999
|
+6.3%
|
|
4Q21
|
-318,686
|
+272.0%
|
|
3Q21
|
-117,240
|
-118.5%
|
|
2Q21
|
-108,444
|
-12.2%
|
|
1Q21
|
-99,714
|
-10.1%
|
|
4Q20
|
-85,668
|
+29.2%
|
|
3Q20
|
633,978
|
-772.5%
|
|
2Q20
|
-123,473
|
+23.9%
|
|
1Q20
|
-110,955
|
+26.9%
|
|
4Q19
|
-66,331
|
-17.4%
|
|
3Q19
|
-94,275
|
+29.6%
|
|
2Q19
|
-99,681
|
+268.5%
|
|
1Q19
|
-87,407
|
+54.6%
|
|
4Q18
|
-80,322
|
+63.8%
|
|
3Q18
|
-72,723
|
+92.9%
|
|
2Q18
|
-27,048
|
-19.0%
|
|
1Q18
|
-56,549
|
+102.1%
|
|
4Q17
|
-49,027
|
+130.6%
|
|
3Q17
|
-37,703
|
+124.0%
|
|
2Q17
|
-33,412
|
+76.8%
|
|
1Q17
|
-27,977
|
+80.5%
|
|
4Q16
|
-21,263
|
+36.5%
|
|
3Q16
|
-16,834
|
+33.2%
|
|
2Q16
|
-18,894
|
+45.6%
|
|
1Q16
|
-15,504
|
+34.0%
|
|
4Q15
|
-15,575
|
-
|
|
3Q15
|
-12,642
|
-
|
|
2Q15
|
-12,980
|
-
|
|
1Q15
|
-11,572
|
-
|